Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. - Deacon,C.F.; Nauck,M.A.; Toft-Nielsen,M. (Diabetes, 1995)